Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.8B | 1.8B | 2.0B | 1.8B |
Cost of revenue | 1.4B | 1.4B | 1.5B | 1.4B |
Gross profit | 438.5M | 437.0M | 458.1M | 430.1M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 351.3M | -683.1M | 367.9M | 335.5M |
Other operating expenses | — | — | — | — |
Operating income | 87.2M | 91.6M | 90.2M | 94.6M |
Non operating interest income | ||||
Income | 11.5M | -4.5M | 17.6M | 4.3M |
Expense | 29.2M | 18.0M | 19.1M | 16.3M |
Other income expense | — | — | — | — |
Pretax income | 72.3M | 82.7M | 87.1M | 82.8M |
Tax provision | 17.4M | 21.5M | 20.9M | 12.9M |
Net income | 54.8M | 61.2M | 66.2M | 69.9M |
Basic EPS | 3.7 | — | 4.4 | 4.8 |
Diluted EPS | 3.7 | — | 4.4 | 4.8 |
Basic average shares | 13.8M | — | 13.8M | 13.8M |
Diluted average shares | 13.8M | — | 13.8M | 13.8M |
EBITDA | 180.0M | 184.2M | 184.4M | 178.4M |
Net income from continuing op. | 54.8M | 61.2M | 66.2M | 69.9M |
Minority interests | -3.9M | -5.4M | -5.3M | -3.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |